Can anyone suggest why the FDA are being so slow in their response regards the p3 trials. It always appeared that it would be a clear cut decision to give the go ahead and yet here they are taking a long time to make a decision , given PAR has fast track designation.
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.010(3.57%) |
Mkt cap ! $119.4M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $143.0K | 502.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4500 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 81631 | 11 |
View Market Depth
| Last trade - 11.52am 18/09/2025 (20 minute delay) ? |
| PAR (ASX) Chart |